Short answer
Eledon Pharmaceuticals, Inc. (ELDN) filed an 8-K current report with the SEC on May 13, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Earnings release covers Eledon’s quarter ended March 31, 2026.
Eledon Pharmaceuticals, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Earnings release covers Eledon’s quarter ended March 31, 2026
- Press release attached as Exhibit 99.1 contains the substantive financial results
- Filing provides no operating figures beyond directing investors to the exhibit
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Eledon Pharmaceuticals, Inc. 8-K filings
Get the next ELDN 8-K as it lands
Follow ELDN for push alerts, or ask the research agent what this filing means.